CJ

Christophe Joseph Marie Le Buhan

Director Additional Director DIN 03131433
DIN 03131433 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Feb 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Christophe Joseph Marie Le Buhan

Data last updated:

Christophe Joseph Marie Le Buhan was an Additional Director at Vovantis Laboratories Private Limited (2010–2013). The company operates in Pharma.

DIN 03131433
Primary Designation Additional Director
Industry Pharma
First Appointment 17 Feb 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director17 Feb 20102008₹76.05 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vovantis Laboratories Private Limited
Premium access

Shareholding and investment profile for Christophe Joseph Marie Le Buhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Christophe Joseph Marie Le Buhan

Christophe Joseph Marie Le Buhan was first appointed on 17 Feb 2010 as Additional Director at Vovantis Laboratories Private Limited.

Christophe Joseph Marie Le Buhan held 1 earlier board appointment: Vovantis Laboratories Private Limited (Additional Director, 17 Feb 2010 to 25 Nov 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available